Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 6
Submit an article Journal homepage
261
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia

Pieralessandro Lasalviaa Department of Economic Studies, NeuroEconomix, Bogota, ColombiaCorrespondence[email protected]
View further author information
,
Yaneth Gil-Rojasa Department of Economic Studies, NeuroEconomix, Bogota, ColombiaView further author information
&
Ángel Garcíab Cardiology Unit, San Ignacio University Hospital. Pontificia Universidad Javeriana, Bogotá, ColombiaView further author information
Pages 955-964 | Received 13 Sep 2021, Accepted 16 Feb 2022, Published online: 08 Mar 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.